Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |